CDH18 is a fetal epicardial biomarker regulating differentiation towards vascular smooth muscle cells
-
- Junghof, Julia
- Center for iPS Cell Research and Application, Kyoto University; Graduate School of Medicine, Kyoto University
-
- 小暮, 優太
- Center for iPS Cell Research and Application, Kyoto University; Research and Development Division, ROHTO Pharmaceutical Co., Ltd.
-
- 田, 雨
- Center for iPS Cell Research and Application, Kyoto University; Graduate School of Medicine, Kyoto University
-
- Verdugo-Sivianes, Eva María
- Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas; CIBERONC, Instituto de Salud Carlos III
-
- 成田, 恵
- Center for iPS Cell Research and Application, Kyoto University
-
- Lucena-Cacace, Antonio
- Center for iPS Cell Research and Application, Kyoto University
-
- 吉田, 善紀
- Center for iPS Cell Research and Application, Kyoto University
書誌事項
- 公開日
- 2022
- 資源種別
- journal article
- 権利情報
-
- © The Author(s) 2022
- This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
- DOI
-
- 10.1038/s41536-022-00207-w
- 公開者
- Springer Nature
説明
The epicardium is a mesothelial layer covering the myocardium serving as a progenitor source during cardiac development. The epicardium reactivates upon cardiac injury supporting cardiac repair and regeneration. Fine-tuned balanced signaling regulates cell plasticity and cell-fate decisions of epicardial-derived cells (EPCDs) via epicardial-to-mesenchymal transition (EMT). However, powerful tools to investigate epicardial function, including markers with pivotal roles in developmental signaling, are still lacking. Here, we recapitulated epicardiogenesis using human induced pluripotent stem cells (hiPSCs) and identified type II classical cadherin CDH18 as a biomarker defining lineage specification in human active epicardium. The loss of CDH18 led to the onset of EMT and specific differentiation towards cardiac smooth muscle cells. Furthermore, GATA4 regulated epicardial CDH18 expression. These results highlight the importance of tracing CDH18 expression in hiPSC-derived epicardial cells, providing a model for investigating epicardial function in human development and disease and enabling new possibilities for regenerative medicine.
収録刊行物
-
- npj Regenerative Medicine
-
npj Regenerative Medicine 7 2022
Springer Nature
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050854065038696192
-
- NII論文ID
- 120007189267
-
- ISSN
- 20573995
-
- HANDLE
- 10668/19558
- 10261/270115
- 2433/267904
-
- PubMed
- 35110584
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE

